Thursday, 26 March 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 26 March 2026
Ascott 2
Ascott 2
Who's on the PBAC's July Agenda?

The PBAC has dropped a packed agenda for its July meeting featuring 50 submissions - including more than 15 innovative drugs looking to make their debut on the PBS.

Companies chase listing changes
A dozen pharmas are seeking to change up existing PBS listings - one wants a revised risk sharing arrangement another, a better price
TODAY
More head-turning data arrives
This ASX-listed company has reported a 100 per cent overall response rate in preliminary data... and it's not the first time
TODAY
Why it's quitting time for pharma
Industry recruitment specialists have warned to brace for resignations as bonuses land in bank accounts
25 March
PBS giant hangs on tight
A mega-blockbuster is tumbling off a patent cliff in Europe and the US, but the Australian market is a much-needed bright spot
25 March
Most expensive drug out of stock
The most expensive drug approved for use in Australia is suffering supply issues, leading to a temporary global stockout
24 March
Where Drs say pharma falls short
New survey has found a monster value gap between industry's delivery of information and 'practical usefulness'
24 March
Latest Jobs
Which pharmas are Most Ethical?
Five pharmas have been honoured amongst the World's Most Ethical Companies, and Ethisphere says it pays off in the share price
25 March
New Horizon for Aussie research
Joining Horizon Europe will benefit local research and development, and align our HTA processes more closely with Europe's
25 March
Roche takes lead in AI race
Swiss giant does a deal for the largest networked computing power in pharma to support otherwise impossible discoveries
25 March
Call out for Aussie innovators
Gilead is funding fellowships for local, innovative, practice-focused projects researching ways to improve the patient experience
24 March
'Weeks away' from supply choke
Logistics expert warns supply of some of Australia's highest-volume medicines could be hit if Strait of Hormuz stand-off escalates
24 March
$90B time bomb exposed
Australia could face a $90 billion-a-year crisis within a decade without coordinated policy action, including access to new therapies
24 March
Ex-J&J staffer sued for secrets 'theft'
Pharma giant claims ex-employee committed industrial espionage after bad performance review, downloading 7000 confidential files
23 March
Fresh fallout from PBAC rejections
Aside from the clear impact on patients, PBAC rejections are taking a human toll on staffers within pharma companies
23 March
Who's back in Aust for a new role?
After six years in Canada - and 25 years at Roche - this high-flyer has been snapped up by a rival company for a newly-created role
23 March
Manufacturing site inks deal
First Aussie commercial viral-vector manufacturing site enters agreement with a company well-known to Big Pharma
23 March
Copy of popular ADHD drug ticked
TGA approves the first generic version of an ADHD drug, which saw a 29 per cent year-on-year increase in pre-rebate PBS benefits
23 March Approvals Action
CEO's $29 million Swan Song
Boss scores a 50 per cent pay rise in final year as CEO for "outstanding leadership" and she's still getting paid
20 March
A dozen drugs hit listing limbo
ICYMI: Twelve drugs from the PBAC's November meeting stall plus the other most popular stories this week
20 March Your Week in 5 Minutes
Companies ready to file new drugs
Novel drugs and new indications are set to be filed in Australia after the TGA handed out the first pathways for registration for 2026
20 March
PiF Advertise
PiF Advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.